Boule Diagnostics AB (publ) announced a private placement of shares on September 7, 2022. The transaction included participation from returning investor, Keel Capital Ab which has increased its ownership to over 5 percent of the shares through this round.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 SEK | -6.85% | +5.37% | -9.09% |
May. 08 | Boule Diagnostics AB Appoints Rikke Rytter as Director | CI |
May. 07 | Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.09% | 36.99M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- BOUL Stock
- News Boule Diagnostics AB
- Boule Diagnostics AB announced that it has received funding from Keel Capital Ab